Drug Information

Drug General Information
Drug ID
D04LIR
Former ID
DIB007235
Drug Name
PD-159913
Drug Type
Small molecular drug
Indication Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] Terminated [546429]
Company
Pfizer Inc
Formula
C20H20NO5P
Canonical SMILES
N[C@@H](Cc1cc(CP(=O)(O)O)cc(c1)c2ccc3ccccc3c2)C(=O)O
InChI
1S/C20H20NO5P/c21-19(20(22)23)10-13-7-14(12-27(24,25)26)9-18(8-13)17-6-5-15-3-1-2-4-16(15)11-17/h1-9,11,19H,10,12,21H2,(H,22,23)(H2,24,25,26)/t19-/m0/s1
InChIKey
GOPXMKDIVJBBQF-IBGZPJMESA-N
PubChem Compound ID
10430161
Target and Pathway
Target(s) NMDA receptor Target Info Modulator [550138]
References
Ref 546429Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008061)
Ref 550138WO patent application no. 2009,0164,86, Use of nmda receptor antagonists for treatment of urologic tumors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.